Invitae

ISIN US46185L1035

 | 

WKN A14NKG

Market cap (in EUR)
4.29 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.
Show more Show less
Healthcare Healthcare Services Patient Care United States

Financials

Key metrics

Market capitalisation, EUR 4.29 m
EPS, EUR -5.04
P/B ratio 2.28
P/E ratio -
Dividend yield 0.00%

Income statement (2022)

Revenue, EUR 490.98 m
Net income, EUR -2,953.94 m
Profit margin -601.64%

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
 
Broker Rating Execution fee Account fee
0.00€
0.00€
View offer*
0.00€
0.00€
View offer*
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.